Moderna shares fall despite promising data from cancer vaccine trial

Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.

LocalNews LocalNews
Apr 18, 2023 - 01:00
0 7
Moderna shares fall despite promising data from cancer vaccine trial
Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.
Read More